At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
Whether it’s running a marathon or helping businesses thrive in applying new technology innovations at scale, we understand what it takes to keep pushing the limits of what’s possible.
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
Tejas Almelkar
Product Manager, TCS ADD Safety, TCS
Dr. Alejandra Guerchicoff
Industry Leader – TCS ADD Safety, TCS
Please fill this form to download or click here to download directly.
Thank you for getting in touch
We will get back to you soon.
More about us
You have these already downloaded
We have sent you a copy of the report to your email again.
The Life Sciences (LS) industry handles large amounts of health and safety data from Research & Development, Clinical Trials, Post-marketing and Real-World Data. The volume of datasets and metadata has rapidly exceeded the capability for humans to process, handle, and review them. Despite this, LS has been slower than others to adopt and embrace AI based automation. Cognitive and intelligent platforms have a huge potential to drive safety case processing efficiencies and over time, replace the traditional PV systems.
There are multiple reasons, factors, and challenges that can be attributed to the slow adoption rate, but in the present article we will focus our attention on “TRANSPARENCY”, a factor that explains the interpretability and explainability of AI algorithms and determinations.
Transparency in AI models shall help understand the nature of errors, improve quality, efficiencies, human governance over machines, and facilitate corrective actions. We believe that truly transparent AI models have the ability to exponentially drive the adoption of AI/ML in pharmacovigilance.
Learn how we can help you bring drugs to the market faster.
Talk to our experts